Generic Emtriva

Although the first two patents for Emtriva (emtricitabine) have expired, there are currently no generic versions of the drug being manufactured in the United States. It's difficult to know when a generic version could become available. However, it's likely that it could happen as early as March 2016, when the next patent expires.

Generic Emtriva: An Overview

Emtriva® (emtricitabine) is a prescription medication used to treat HIV and AIDS. Emtriva belongs to a class of medications known as nucleoside reverse transcriptase inhibitors (NRTIs). It is approved for use only in combination with other HIV medications.
 
Emtriva is made by Gilead Sciences, Inc. It is currently under the protection of patents that prevent any generic Emtriva from being manufactured in the United States.
 

When Will Generic Emtriva Be Available?

The first two patents for Emtriva expired in August and November 2010. However, a generic Emtriva is still not available. This strongly suggests that other, later-expiring Emtriva patents provide significant protection from generic competition.
 
The next patent is currently set to expire in March 2016. This is the earliest predictable date that a generic version of Emtriva could become available.
 
However, there are other circumstances that could come up to extend the exclusivity period of Emtriva beyond 2016. This could include things such as other patents for specific Emtriva uses or lawsuits. Once Emtriva goes off patent, there may be several companies that manufacture a generic Emtriva drug.
  

Is Emtricitabine a Generic Version of Emtriva?

The answer is no. Emtricitabine sulfate is the active ingredient in Emtriva, but it is not a generic version of Emtriva. What can be confusing is that, oftentimes, the active ingredient of a drug is referred to as the "generic name." The generic name is different than a generic version of a medicine. All medications have a generic name, regardless of whether there are generic versions available.
 
In order for there to be a generic version of a medicine, the original medicine must have gone off patent and another company (besides the original manufacturer) would make the product.

Emtriva -- HIV Drug Treatment

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.